Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 16, 2025

Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

KBKarin BornfeldtJKJenny E. KanterCHCheng-Chieh Hsu

Discussion

Loading...

Member takes

Overview

Research shows elevated apolipoprotein C3 increases atherosclerosis risk in diabetes, suggesting its role in inflammation and cholesterol accumulation.

Key Points

  • Elevated apolipoprotein c3 levels correspond to a heightened risk of atherosclerosis in diabetes patients.
  • Assessment of plasma apolipoprotein c3 shows stronger predictive ability for cardiovascular disease events in diabetes.
  • Silencing apolipoprotein c3 in mouse models lowers both cholesterol and triglycerides, impacting atherosclerosis development.
  • Single-cell RNA sequencing highlights inflammation as a key driver in macrophages and smooth muscle cells affected by apolipoprotein c3.
  • ],
  • simple_explanation
  • Apolipoprotein C3 is a protein that can increase the risk of heart disease, especially in people with diabetes. High levels of this protein lead to more cholesterol and inflammation in blood vessels. By lowering apolipoprotein C3, it may be possible to reduce these risks and create new treatments for heart disease. Researchers are excited about this potential because it could help many people stay healthier. 🫀

Cite This Study

Bornfeldt et al. (2025) studied this question.

synapsesocial.com/papers/689a02c3e6551bb0af8ccb64https://doi.org/10.21203/rs.3.rs-6979508/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes2024 · 10 citations
  2. 22682-P: Targeting APOC3 Preserves β-Cell Function in a Mouse Model of Type 2 Diabetes2026
  3. 3Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics2015 · 80 citations
  4. 4Apolipoprotein CIII and diabetes. Is there a link?2018 · 21 citations
  5. 5Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)2022 · 80 citations